The website of Pathology In Practice Magazine

New RNase Inhibitor ensures reliable RNA protection

PCR Biosystems has launched RiboShield RNase Inhibitor, a robust and reliable RNase inhibitor that is now available as a standalone product.

RiboShield RNase Inhibitor is a recombinant protein that blocks the activity of a wide range of ribonucleases to protect RNA from RNase digestion. The inhibitor is designed for use in various RNA-sensitive applications including RNA purification, complementary DNA (cDNA) synthesis, RT-PCR, RNA sequencing, and in situ hybridisation.

With such techniques, the presence of even small amounts of RNase can be highly detrimental to RNA quality and experimental outcome. RiboShield RNase Inhibitor also complements PCR Biosystems’s range of products to support SARS-CoV-2 research and testing.

One new application for RiboShield RNase Inhibitor is in saliva-based testing for the presence of SARS-CoV-2. This is currently gaining popularity as it is easy for people to collect their own samples with minimal discomfort compared with the standard nasopharyngeal swab. While the sample is simple to obtain, the digestive enzymes present in saliva represent a hostile environment for RNA. Using an RNase inhibitor is essential to provide adequate RNA protection and generate accurate test results.

RiboShield RNase Inhibitor performs over a wide range of reaction conditions and can inhibit RNases at temperatures up to 65°C for at least 30 minutes. The molecule binds non-covalently at a ratio of 1:1 to inhibit the activity of various ribonucleases, including eukaryotic RNases of the neutral type (RNases A, B and C). The inhibitor does not hinder other enzymes, such as reverse transcriptases, RNA polymerases or Taq DNA polymerase, making it compatible with many enzymatic reactions that utilise RNA.

In addition, the very rapid kinetics of association to RNases guarantees immediate protection of RNA, leading to significantly better performance in applications where RNase contamination is a concern. The RiboShield RNase Inhibitor protein is purified from a strain of Pichia pastoris that expresses a modified human placental gene.

More information on RiboShield and the complete range of products to support RNA analysis and SARS-CoV-2 testing is available here.

Alternatively, to request a free sample, visit https://pcrbio.com/quotes-samples/?_product=7712,

Upcoming Events

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 22/06/2021 13:53:38 Step Communications Ltd. Registered in England. Registration Number 3893025